XML 57 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Millions, unless otherwise specified
Dec. 31, 2011
Dec. 31, 2010
Current assets:    
Cash and cash equivalents $ 246.0 $ 230.4
Restricted cash 2.2 2.9
Accounts receivable, net 282.8 232.9
Inventories 576.2 511.0
Deferred tax assets 11.5 8.6
Other current assets 75.4 65.3
Total current assets 1,194.1 1,051.1
Property, plant and equipment, net 249.0 233.7
Goodwill 100.2 98.3
Intangible assets, net 136.4 136.1
Long-term deferred tax assets 17.2 12.5
Other long-term assets 13.6 18.1
Total assets 1,710.5 1,549.8
Current liabilities:    
Short-term borrowings   185.5
Current portion of long-term debt 83.7 28.9
Accounts payable 72.3 64.0
Customer advances 268.6 242.2
Deferred tax liabilities 11.2 9.2
Other current liabilities 320.0 301.7
Total current liabilities 755.8 831.5
Long-term debt 219.4 86.6
Long-term deferred revenue 32.7 29.3
Long-term deferred tax liabilities 23.8 18.8
Accrued pension 39.2 39.4
Other long-term liabilities 14.7 16.8
Commitments and contingencies (Note 14)      
Shareholders' equity:    
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2011 and 2010      
Common stock, $0.01 par value 260,000,000 shares authorized, 165,892,170 and 165,246,426 shares issued and 165,871,905 and 165,229,207 outstanding at December 31, 2011 and 2010, respectively 1.7 1.6
Treasury stock at cost, 20,265 and 17,219 shares at December 31, 2011 and 2010, respectively (0.2) (0.2)
Additional paid-in capital 36.0 21.7
Retained earnings 441.5 349.2
Accumulated other comprehensive income 142.5 152.4
Total shareholders' equity attributable to Bruker Corporation 621.5 524.7
Noncontrolling interest in consolidated subsidiaries 3.4 2.7
Total shareholders' equity 624.9 527.4
Total liabilities and shareholders' equity $ 1,710.5 $ 1,549.8